EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploring the therapeutic targets of stevioside in management of type 2 diabetes by network pharmacology and in-silico approach

Amit Dutta, Md Arju Hossain, Pratul Dipta Somadder, Mahmuda Akter Moli, Kawsar Ahmed, Md Masuder Rahman, Francis M Bui

Diabetes & Metabolic Syndrome: Clinical Research & Reviews · 2024

DOI: 10.1016/j.dsx.2024.103111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2024. Verfasst von Amit Dutta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, 1902, Bangladesh. Hauptthemen laut MEDLINE: Glucosides, Diterpenes, Kaurane, Network Pharmacology, Molecular Docking Simulation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: The main objective of the current study is to investigate the pathways and therapeutic targets linked to stevioside in the management of T2D using computational approaches. METHODS: We collected RNA-seq datasets from NCBI, then employed GREIN to retrieve differentially expressed genes (DEGs). Computer-assisted techniques DAVID, STRING and NetworkAnalyst were used to explore common significant pathways and therapeutic targets associated with T2D and stevioside. Molecular docking and dynamics simulations were conducted to validate the interaction between stevioside and therapeutic targets. RESULTS: Gene ontology and KEGG analysis revealed that prostaglandin synthesis, IL-17 signaling, inflammatory response, and interleukin signaling were potential pathways targeted by stevioside in T2D. Protein-protein interactions (PPI) analysis identified six common hub proteins (PPARG, PTGS2, CXCL8, CCL2, PTPRC, and EDN1). Molecular docking results showed best binding of stevioside to PPARG (-8 kcal/mol) and PTGS2 (-10.1 kcal/mol). Finally, 100 ns molecular dynamics demonstrated that the binding stability between stevioside and target protein (PPARG and PTGS2) falls within the acceptable range. CONCLUSIONS: This study reveals that stevioside exhibits significant potential in controlling T2D by targeting key pathways and stably binding to PPARG and PTGS2. Further research is necessary to confirm and expand upon these significant computational results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucosidesDiterpenes, KauraneNetwork PharmacologyMolecular Docking SimulationDiabetes Mellitus, Type 2HumansComputer SimulationProtein Interaction MapsMolecular Dynamics SimulationPPAR gamma

Stichwörter der Autor:innen

Molecular dockingMolecular dynamics simulationPPARGPTGS2SteviosideT2D

Substanzen

steviosideGlucosidesDiterpenes, KauranePPAR gamma

Autor:innen und Institutionen

  • Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, 1902, Bangladesh.
  • Department of Microbiology, Primeasia University, Banani, Dhaka, 1213, Bangladesh.
  • Department of Pharmaceuticals and Industrial Biotechnology, Sylhet Agricultural University, Bangladesh.
  • Department of Information and Communication Technology, Mawlana Bhashani Science and Technology University (MBSTU), Santosh, Tangail, 1902, Bangladesh; Department of Electrical and Computer Engineering, University of Sa…
  • Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, 1902, Bangladesh. Electronic address: masudmbstu@gmail.com.
  • Department of Electrical and Computer Engineering, University of Saskatchewan, 57 Campus Drive, Saskatoon, SK, S7N 5A9, Canada.

Förderung

  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Dutta, A., Hossain, M. A., Somadder, P. D., Moli, M. A., Ahmed, K., Rahman, M. M., & Bui, F. M. (2024). Exploring the therapeutic targets of stevioside in management of type 2 diabetes by network pharmacology and in-silico approach. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. https://doi.org/10.1016/j.dsx.2024.103111

Vancouver

Dutta A, Hossain MA, Somadder PD, Moli MA, Ahmed K, Rahman MM, et al. Exploring the therapeutic targets of stevioside in management of type 2 diabetes by network pharmacology and in-silico approach. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2024. doi:10.1016/j.dsx.2024.103111

BibTeX
@article{Dutta2024,
  author = {Dutta, Amit and Hossain, Md Arju and Somadder, Pratul Dipta and Moli, Mahmuda Akter and Ahmed, Kawsar and Rahman, Md Masuder and Bui, Francis M},
  title = {Exploring the therapeutic targets of stevioside in management of type 2 diabetes by network pharmacology and in-silico approach},
  journal = {Diabetes & Metabolic Syndrome: Clinical Research & Reviews},
  year = {2024},
  doi = {10.1016/j.dsx.2024.103111}
}
Kostenlos starten →